Market Cap 146.75M
Revenue (ttm) 0.00
Net Income (ttm) -55.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.24
Volume 662,000
Avg Vol 2,092,844
Day's Range N/A - N/A
Shares Out 59.90M
Stochastic %K 98%
Beta 0.68
Analysts Strong Sell
Price Target $8.50

Latest News on ALDX

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors

Apr 17, 2025, 7:00 AM EDT - 7 weeks ago

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors